Status:

COMPLETED

Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine Addiction

Opiate Addiction

Eligibility:

All Genders

18-65 years

Brief Summary

Background: * The treatment of addiction often hinges on preventing relapse into drug-using behaviors, which occurs at high rates even after prolonged abstinence. Research has shown that constant rep...

Detailed Description

Background. We have already completed the original, major arm of this protocol (a natural-history study of craving and lapse). Still open for enrollment is the second minor arm (a within-subject trial...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Age between 18 and 65;
  • Evidence of physical dependence on opioids (self-report and physical exam);
  • Evidence of cocaine and opiate use (self-report and urine screen).
  • \<TAB\>
  • EXCLUSION CRITERIA:
  • Schizophrenia or any other DSM-IV psychotic disorder; history of bipolar disorder; current Major Depressive Disorder;
  • Current dependence on alcohol or sedative-hypnotic, e.g. benzodiazepine (by DSM-IV criteria);
  • Cognitive impairment severe enough to preclude informed consent or valid self-report;
  • Medical illness that in the view of the investigators would compromise participation in research;
  • Urologic conditions that would inhibit urine collection;
  • In arm 2 only: current or recent maintenance on a methadone dose substantially higher than the arm 2 ceiling dose of 100 mg/day; the MRP will evaluate this case by case.

Exclusion

    Key Trial Info

    Start Date :

    August 15 2003

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 11 2013

    Estimated Enrollment :

    230 Patients enrolled

    Trial Details

    Trial ID

    NCT00292136

    Start Date

    August 15 2003

    End Date

    June 11 2013

    Last Update

    April 5 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institute on Drug Abuse

    Baltimore, Maryland, United States, 21224